Experiments examined activational roles of gonadal steroids on the sexually dimorphic, calcitonin gene-related peptideexpressing neurons of the rat preoptic area. Gonadectomy of male rats followed by treatment with testosterone, dihydrotestosterone, or estrogen demonstrated that the tonic suppressive influence of testosterone on cellular levels of calcitonin gene-related peptide mRNA expression in the medial preoptic nucleus and anteroventral periventricular nucleus occurred through either ER-or AR-mediated mechanisms (P < 0.05). The gonadectomy of adult female rats demonstrated little tonic influence of ovarian steroids upon calcitonin gene-related peptide mRNA levels. However, the administration of male levels of testosterone to ovariectomized rats resulted in reduced calcitonin gene-related peptide mRNA expression within the medial preoptic nucleus (P < 0.05) and, strikingly, a 3-fold induction in calcitonin gene-related peptide mRNA expression in the anteroventral periventricular nucleus (P < 0.01). Testosterone's effects in the medial preoptic nucleus and anteroventral periventricular nucleus of the female required both ER and AR activation. Dual labeling immunocytochemical studies revealed that less than 10% of calcitonin gene-related peptide neurons in the male expressed ARs compared with approximately 50% in the female. These investigations reveal that sexually differentiated region-and steroid receptor-specific mechanisms function in association with the sex differences in circulating gonadal steroids to maintain the sexually dimorphic nature of calcitonin gene-related peptide expression in the preoptic area of the adult rat. (Endocrinology 142: 3397-3404, 2001) 
T HE SEXUAL DIFFERENTIATION of the mammalian
brain is thought to occur primarily as the result of differences in neuronal and glial cell exposure to gonadal steroid hormones (1) (2) (3) (4) (5) (6) . Perinatally, the elevated testosterone levels found in the male are believed to act in an "organizational" fashion to permanently masculinize specific brain regions (1) (2) (3) (4) (5) (6) . In the adult, circulating gonadal steroids exert further sexually differentiated suppressive and stimulatory "activational" effects on neuronal activity (2, 6) . Substantial experimental evidence in the rodent supports the hypothesis that the sexually differentiating effects of testosterone during the perinatal period are mediated principally by estrogen generated from the aromatization of testosterone (1) (2) (3) (4) (5) (6) . However, the mechanisms underlying the activational effects of gonadal steroids in the adult appear to be more complex. Not only is testosterone metabolized to dihydrotestosterone (DHT) and estrogen, capable of activating androgen and the estrogen receptors, respectively, but gonadal steroids of ovarian origin are thought to play distinct roles (2, 6, 7) .
The medial preoptic area of the rodent represents one of the best defined brain regions in terms of sexually differentiated neuronal architecture. Sex differences in the morphology, size of distinct nuclei, and numbers of specific, neurochemically defined neurons have all been described in this brain region (1, 2, 8 -15) . One such sexually dimorphic neuronal population identified in the rat is that synthesizing the neuropeptide ␣-calcitonin gene-related peptide (CGRP) (16, 17) . These neurons are located almost exclusively within the anteroventral periventricular nucleus (AVPV) and medial preoptic nucleus (MPN) of the medial preoptic area and are more numerous in the female than in the male (16) . Immunocytochemical and in situ hybridization investigations suggest that testosterone exerts both organizational and activational effects on these cells, which result in an almost complete suppression of preoptic CGRP expression in the male (17, 18) . Around postnatal d 5, testosterone exerts an organizational effect to set the maximum number of potential CGRP-expressing cells to approximately one third of that observed in the female (17) . Then, in the adult male, testosterone exerts its activational influence to suppress CGRP mRNA and protein expression in these neurons (18) . Although a subpopulation of preoptic CGRP neurons is known to be activated after lordosis in the female rat (19) , the physiological role(s) of these neurons is not yet established.
Because of the robust sex difference that exists in CGRP cell number and the clear dual organizational-activational effects of testosterone on these neurons, we reasoned that these cells might represent a good model to explore the precise impact of perinatal sexual differentiation on activational responses in the adult. In particular, it is not always clear whether activational sex differences are dependent upon sexually dimorphic molecular imprints from the perinatal period or, more simply, defined by the differing gonadal steroid levels of adult males and females. Based upon our earlier findings (17, 18) , we hypothesized that activational sex differences in the regulation of CGRP expression may depend solely upon male-female differences in circulating testosterone concentrations. We have examined these activational effects in the present study by administering male levels of testosterone to gonadectomized male and female rats and by examining the AR-and ER-dependent pathways involved in each sex. To establish whether any effects of androgens might be direct, we have also undertaken a series of dual labeling immunocytochemical studies examining the relationship between ARs and preoptic area CGRP neurons. A previous study had identified a sexually dimorphic pattern of ER␣ expression in preoptic CGRP neurons (20) .
Materials and Methods
Adult male and female Wistar rats (200 -250 g; ϳ90 d of age for each sex) from the Babraham colony were maintained in a light-and temperaturecontrolled environment (lights on at 0500 h, off at 1900 h; 22 C) with food and water freely available. All surgical procedures were carried out on animals anesthetized with Avertin (2% tribromoethanol; 1 ml/100 g BW, ip), and animals were treated in accordance with United Kingdom Home Office regulations under Project 80/1005.
Exp 1: effect of gonadal steroid manipulation on CGRP mRNA expression
Twenty-four male and 24 female adult rats were bilaterally gonadectomized under Avertin anesthesia. Four weeks later, animals of each sex were divided into 4 equal groups (n ϭ 6) and implanted sc with SILASTIC brand capsules (SILASTIC medical grade tubing; od, 0.062 in.; od, 0.125 in.; Dow Corning Corp., Midland, MI) containing testosterone crystals (30-mm-long capsule; group 1), DHT crystals (20 mm-long capsule; group 2), 17␤-estradiol (50 g/ml sesame oil in 14-mm-long capsule; group 3), or sesame oil alone (14-mm-long capsule; group 4) for 1 wk. All steroids were obtained from Sigma (Poole, UK). These gonadal steroid replacement paradigms have been shown previously to achieve the plasma concentrations of testosterone (ϳ3 ng/ml), DHT (ϳ1.0 ng/ ml), and estradiol (ϳ20 pg/ml) that are within the physiological range for male rats (21) (22) (23) (24) . In addition to these 48 gonadectomized animals, 6 intact males and 6 female animals exhibiting at least 2 consecutive 4-d estrous cycles were killed on the next day of diestrus.
Male and female rats were killed 1 wk after capsule implantation alongside intact rats (all animals were ϳ90 d of age) by cervical dislocation and decapitation between 1000 -1200 h. The brains were quickly removed, frozen on dry ice, and stored at Ϫ70 C until processing for in situ hybridization experiments. Trunk blood from each rat was collected into a heparinized beaker and centrifuged, and the plasma supernatant was stored at Ϫ20 C until used for analysis of testosterone levels by RIA.
Exp 2: effects of testosterone and combined estrogen and DHT treatment on CGRP mRNA expression in female rats
Eighteen adult female rats were ovariectomized under Avertin anesthesia and 4 wk later were divided into three equal groups of six animals and implanted with SILASTIC capsules. Rats in the first group received a 2-mm-long capsule filled with testosterone crystals; rats in the second group received a 14-mm-long capsule filled with estradiol (50 g 17␤-estradiol crystals/ml sesame oil) as well as a 20-mm-long capsule filled with DHT crystals, and rats in the third group received a 20-mmlong capsule filled with sesame oil. Female rats were killed 1 wk after capsule implantation by cervical dislocation and decapitation between 1000 and 1200 h. The brains were quickly removed, frozen on dry ice, and stored at Ϫ70 C until processing for in situ hybridization experiments. Trunk blood from each rat was collected into a heparinized beaker and centrifuged, and the plasma supernatant was stored at Ϫ20 C until used for analysis of testosterone levels by RIA.
In situ hybridization analysis of CGRP mRNA expression. Fresh-frozen sections (15 m thick) were cut in the coronal plane through the entire preoptic area on a cryostat and thaw-mounted onto Vectabond (Vector Laboratories, Inc., Peterborough, UK) coated slides. Sections were kept at Ϫ70 C until used. In situ hybridization for CGRP mRNA was undertaken as described previously (18) 9 cpm/g. Frozen sections from all animal groups were processed simultaneously. One complete set of sections in Exp 1 and 2 underwent hybridization using an equimolar cocktail of the three labeled CGRP probes diluted in hybridization buffer (final concentration, ϳ6 ϫ 10 3 cpm/ml). After an overnight hybridization at 37 C, sections were washed in 1 ϫ SSC (standard saline citrate) at room temperature, three times in 1 ϫ SSC at 55 C (30 min each), and again in 1 ϫ SSC for 1 h at room temperature. Slides were then dipped in Ilford K-5 nuclear track emulsion (Ilford Imaging UK, Cheshire, UK) and exposed for 17 d in light-tight boxes. At the appropriate exposure time, as determined by test slides taken off at weekly intervals, all slides were photodeveloped with Ilford phenisol and lightly counterstained with methylene blue. Signal specificity was assessed by use of competition experiments in which the three radiolabeled probes were applied to sections in the presence of a 25-fold excess of each unlabeled probe.
Analysis. The analysis of relative CGRP mRNA expression was undertaken by an investigator blind to the experimental groups of the rats. Expression was determined by computer-assisted analysis (Seescan, Cambridge, UK) of silver grain density overlying individual cells and also by cell counts of positively labeled cells within the AVPV and MPN, as reported previously (18) . The boundaries of the AVPV and MPN were defined by reference to the characteristic landmarks of the preoptic area and cell densities as reflected in the methylene blue counterstaining, with the rostro-caudal extent of the AVPV and MPN corresponding to plates 17-19 and 20 -23 of Swanson (25), respectively. The delineation of these nuclei was further assisted by the distribution of CGRP mRNAexpressing cells, which at these coronal levels are found almost exclusively in the AVPV and MPN (16) .
For the silver grain analysis, the mean silver grain density overlying individual hybridized AVPV and MPN cells was determined in control excess unlabeled probe sections, and in experimental sections, only those cells expressing numbers of silver grains 5 times the control value were used for analysis (18) . In each animal the silver grain density of at least 30 AVPV and at least 30 MPN cells counted from both sides of the brain and from 2-3 different sections were analyzed. For each rat, an average silver grain density per cell was determined, and these values combined to give experimental group means. The number of cells expressing CGRP mRNA in each animal was assessed by counting the total number of positively hybridized cells located within the AVPV and MPN in a minimum of 4 hemisections from each animal. Section counts were used to provide individual animal averages and then were combined to provide group means. In all cases statistical analysis was undertaken using nonparametric ANOVA with the Student-Newman-Keuls post-hoc significance test.
Exp 3: immunocytochemical investigation of the presence of ARs in preoptic CGRP neurons
Six male and six female adult rats were anesthetized with Avertin, placed in a stereotaxic frame, and given an injection of 50 g colchicine (2.5 l of a 20 g/l solution in 0.9% saline) into the third ventricle. Twenty-four hours later, the animals were anesthetized with Avertin and perfused transcardially with heparinized saline (25 IU/ml isotonic saline) followed by 4% paraformaldehyde in 0.1 m phosphate buffer (pH 7.6) for 15 min. The brains were removed and postfixed for 1 h in 4% paraformaldehyde before being transferred to a 30% sucrose Trisbuffered saline solution overnight.
Immunocytochemistry. Brain sections (25 m thick) were cut in the coronal plane on a freezing microtome, and three sets of sections encompassing the entire preoptic area collected. One set of freefloating sections was then processed for AR immunocytochemistry as described previously (26). Briefly, sections were incubated in a polyclonal rabbit antisera directed against the N-terminal region of the androgen receptor (PG-21, 1 g/ml; gift of G. Prins, Chicago, IL) and then placed in biotinylated goat antirabbit Igs (1:200; Vector Laboratories, Inc., followed by the Vector Elite Kit (1:100) for 90 min. AR immunoreactivity was then visualized using a glucose-oxidasenickel-3,3-diaminobenzidine tetrahydrochloride procedure. For the CGRP dual labeling, AR-stained sections were placed in rabbit polyclonal antisera raised against ␣CGRP (1:3000; Amersham International, Little Chalfont, UK) for 48 h at 4 C, followed by peroxidaselabeled goat antirabbit antibodies (1:200; Vector Laboratories, Inc.) for 4 h at room temperature. CGRP immunoreactivity was visualized using the same glucose oxidase-3,3-diaminobenzidine tetrahydrochloride method as above but without the nickel. The production and specificity of the AR and CGRP antisera used in the present study have been reported previously by others and ourselves (17, 26 -29) . Control experiments included the omission of either primary antiserum or the use of AR antisera incubated overnight with a 20-fold molar excess of the peptide AR-21 (0.8 g/ml) used to generate the PG-21 antibody. Both procedures resulted in a complete absence of specific staining.
Analysis. All CGRP-immunoreactive (IR), AR-IR, and (CGRPϩAR)-IR cell profiles were counted within the boundaries of the AVPV and MPN using a Orthoplan microscope (Leica Corp., Rockleigh, NJ) at ϫ40 -100 magnification. Cell profiles exhibiting black nuclear staining associated with brown cytoplasmic immunoreactivity were considered double labeled. Cell counting was carried out on a minimum of six hemisections per animal from both the AVPV and MPN, and counts were combined to give mean numbers of single and double labeled cells per hemisection for males and females in the AVPV and MPN. Statistical analysis was undertaken using the nonparametric Mann-Whitney U test.
RIA for testosterone. The testosterone concentrations of all plasma samples were assayed in a single RIA using a Coat-a-Count kit (Diagnostic Products, Los Angeles, CA). Samples of known concentration were used to produce a calibration curve from which sample testosterone concentrations were directly measured. The sensitivity of the assay was 0.01 ng/ml, and the intraassay coefficient of variation was 9.8%.
Results

In situ hybridization for CGRP mRNA
Within the preoptic area, cells displaying silver grain clusters were detected almost exclusively within AVPV (Fig. 1 ) and caudal and lateral aspects of the MPN. No clusters of silver grains were detected in sections hybridized with radiolabeled probes in the presence of excess unlabeled probes.
These findings are in excellent agreement with previous in situ hybridization and immunocytochemical studies (16 -18) and indicate the specificity of the procedure for detecting ␣CGRP mRNA.
Exp 1: effect of gonadal steroid manipulation on silver grain expression
Intact male and female rats. The numbers of hybridized cells identified in the MPN were significantly higher in females (16 Ϯ 1 cells/section) than in males (8 Ϯ 0.5; P Ͻ 0.01), and the same was found in the AVPV (females, 10.6 Ϯ 0.7; males, 6.8 Ϯ 0.9; P Ͻ 0.01; Figs. 2 and 3) . (Figs. 2 and 3) .
Regulation of CGRP mRNA expression in the male. In both the MPN and AVPV, gonadectomy resulted in a significant increase in the numbers of hybridized cells detected (P Ͻ 0.01) as well as their mean silver grain density (P Ͻ 0.05; Fig. 2) . Each of the gonadal steroid treatments (testosterone, DHT, or estrogen) returned the numbers of hybridized cells and their silver grain densities to intact levels in both the MPN and AVPV (P Ͻ 0.05 for all parameters; Fig. 2) .
Mean plasma testosterone concentrations were significantly reduced in gonadectomized, oil-treated males (Ͻ0.01 ng/ml) compared with those in intact animals (3.6 Ϯ 0.6 ng/ml). Treatment with testosterone returned levels to normal (2.7 Ϯ 0.2 mg/ml), while testosterone concentrations remained low (all Ͻ0.03 ng/ml) after the administration of either estrogen or DHT. Regulation of CGRP mRNA expression in the female. Ovariectomy had no effect on the numbers of hybridized cells detected in either the MPN or AVPV (Fig. 3A) of the female rat. However, testosterone administration to ovariectomized rats significantly reduced cell numbers in the MPN (P Ͻ 0.05) while dramatically increasing cell numbers in the AVPV (P Ͻ 0.01; Fig. 3A) . The effects of testosterone were not mirrored by DHT or estrogen treatment alone. 
FIG. 2. Histograms displaying the mean (ϮSEM) numbers of cells expressing silver grains (A) or cellular silver grain densities (B) after hybridization
for CGRP mRNA in the MPN and AVPV of intact male rats and gonadectomized (GDX) males treated with oil, testosterone (T), DHT, or estradiol (E). n ϭ 6 in each group. *, P Ͻ 0.05; **, P Ͻ 0.01 (compared with all other groups).
In terms of cellular silver grain density, ovariectomy increased expression in the MPN (P Ͻ 0.01), and this was returned to normal levels by testosterone, DHT, or estrogen (P Ͻ 0.05 for each; Fig. 3B ). In the AVPV, gonadectomy was found to have no effect on silver grain density, but, like the cell number data, testosterone alone increased cellular mRNA levels (P Ͻ 0.01; Fig. 3B ).
Mean plasma testosterone concentrations were 3.1 Ϯ 0.2 ng/ml in ovariectomized, testosterone-treated females (not significantly different compared with intact males or gonadectomized, testosterone-treated males), 0.2 Ϯ 0.2 ng/ml in gonadectomized DHT-treated animals, and less than 0.03 ng/ml in the vehicle-and estrogen-treated rats.
Exp 2: gonadal steroid receptor pathways mediating the effects of testosterone on CGRP mRNA expression in female rats
As changes in CGRP mRNA expression were observed in the MPN of females after testosterone treatment, but not DHT or estradiol alone, we undertook a further study to examine whether DHT and estradiol may be acting synergistically to replicate the effects of testosterone. In this experiment we also used a lower dose of testosterone to investigate whether a dose-response relationship existed for the dramatic stimulatory effects of testosterone on CGRP mRNA expression in the female AVPV. Testosterone concentrations in ovariectomized, testosterone-treated female rats in this experiment were 0.9 Ϯ 0.2 ng/ml, whereas levels in the oil-treated and combined estrogen-and DHT-treated females were less than 0.03 ng/ml in all cases.
As found in Exp 1, testosterone caused a significant reduction in the number of hybridized cells (P Ͻ 0.05) and their cellular silver grain density (P Ͻ 0.001; Fig. 4 ) in female MPN. Combined DHT and estrogen treatment was found to replicate the suppressive actions of testosterone in the MPN (Fig.  4) . In the AVPV, the lower dose of testosterone still induced a marked increase in the numbers of CGRP mRNA-expressing cells (P Ͻ 0.01; Fig. 4A ), and this effect was replicated by the administration of both DHT and estrogen together. The lower levels of testosterone did not, however, alter cellular silver grain density in the AVPV. Combined DHT and estrogen was similarly without effect (Fig. 4B ).
Exp 3: immunocytochemical investigation of the presence of ARs in preoptic CGRP neurons
Both male and female rats exhibited a similar distribution of AR immunoreactivity, which was identical to that reported previously by others (29) and ourselves (26). Within the preoptic area, AR-IR cells were detected within both the AVPV and MPN (Fig. 5) . Although there was a trend toward fewer AR-IR cells per section in the female in both preoptic nuclei, this was not significantly different (Table 1) .
In the female, CGRP-IR neurons were detected throughout the AVPV and within the caudal and lateral aspects of the MPN as reported previously (16, 17) and in agreement with the in situ hybridization findings of this study. The number of CGRP-IR neurons detected in females was significantly greater than that in males in both the AVPV and MPN (P Ͻ 0.05; Table 1 ).
Dual labeled cells exhibited black nuclear-located AR staining combined with light brown cytoplasmic CGRP immunoreactivity (Fig. 5 ) and were identified in both the AVPV and MPN. Dual labeled cells were rare in the male (9%) compared with the female; about 50% of CGRP neurons in the female MPN expressed ARs (P Ͻ 0.01; Table 1 ). Similarly, approximately 35% of CGRP neurons in the female AVPV expressed AR immunoreactivity compared with only approximately 3% in the male (P Ͻ 0.01; Table 1 ).
Discussion
Using quantitative in situ hybridization, we show here that testosterone maintains a tonic suppressive influence on CGRP mRNA expression in the preoptic area of the adult male and that the same pattern of regulation exists in the MPN and AVPV. In contrast, we found relatively little evidence in the female for a tonic influence of gonadal steroids on preoptic area CGRP mRNA expression. However, when female rats were administered male levels of testosterone, CGRP expression in the female MPN responded in a similar manner to that of the male. Unexpectedly, the AVPV dis- played a unique stimulatory response to testosterone. In terms of the receptors involved in these responses, we show that CGRP mRNA levels in the male can be suppressed by either DHT or estrogen alone, whereas effects of testosterone in the female appear likely to require both ER and AR activation. Finally, we identified a marked sex difference in the expression of AR immunoreactivity in CGRP neurons, which, surprisingly, is predominant in the female. Together, these studies indicate that sex differences exist in the activational effects of gonadal steroids on the preoptic CGRP neurons and that, in the female, this regulation is strikingly different between the MPN and AVPV.
Regulation of preoptic CGRP mRNA expression in the male
Our earlier studies demonstrated that testosterone acts in the early neonatal period as well as during adulthood to restrict and then suppress CGRP biosynthesis, in line with the well accepted organizational-activational model of sexual differentiation (1) (2) (3) (4) . In good agreement with our earlier observations in the MPN (18) , gonadectomy of adult male rats elevated CGRP mRNA expression, so that the numbers of hybridized cells detected as well as their CGRP mRNA content were significantly increased in the MPN and AVPV. This clearly indicates that CGRP mRNA expression in both preoptic nuclei is tonically inhibited by gonadal steroids in the male. As replacements with testosterone, DHT, and estrogen to physiological concentrations were all equally effective in returning preoptic CGRP mRNA levels to intact levels, it would appear that the suppressive effect of testosterone on CGRP can occur through the AR or the ER.
The observation that either the AR or ER can mediate the effects of testosterone on CGRP mRNA expression in the male is unusual. Relatively little work has been undertaken to define the steroid receptors underlying the activational effects of gonadal steroids on sexually dimorphic neuronal populations. However, published work examining both ER and AR pathways often indicates the involvement of a just a single receptor type. For example, we have previously demonstrated that testosterone acts through the ER, and not the AR, to regulate GnRH mRNA expression in the male rat using exactly the same steroid treatment paradigms employed in this study (30) . In contrast, the expression of somatostatin mRNA in the sexually dimorphic somatostatin periventricular neurons is clearly stimulated exclusively by AR-dependent mechanisms in the adult rat (31, 32) . The only other example where testosterone has been shown to act through either the ER or AR in brain sexual differentiation involves the perinatal influence of testosterone on growthassociated protein-43 mRNA (34). In contrast, dual ER/AR activation is required to correctly regulate vasopressin expression in the bed nucleus of the stria terminalis (33) .
The involvement of either ER or ARs in the regulation of CGRP mRNA expression in the adult male raises interesting questions regarding the molecular nature of steroid action on these cells. On the one hand, it is possible that the CGRP gene expression is suppressed by either ER or AR directly. The observation of a near-perfect estrogen response element (GGTCCcttTGACC) within the CGRP gene (20) provides at least theoretical support for this possibility. However, the finding here that relatively few CGRP neurons in the male express ARs (Ͻ10%) or ER␣ (ϳ33%; Table 1) suggests that a direct genomic mechanism of gene regulation may not exist for these cells. Thus, these dual suppressive effects through the ER and AR may be indirect or occurring through nonclassical pathways. In this light, it is interesting to note that estrogen regulates neurotensin gene transcription in sexually dimorphic preoptic neurons through cAMP-and PKA-mediated mechanisms (15, 35) . Future studies will be required to establish precisely how testosterone down-regulates CGRP expression in the male rat. As we do not yet know whether these cells express aromatase, it is also unclear which of these receptor pathways might be most important in vivo under normal circumstances. The marked uniformity in testosterone's suppressive influence on CGRP immunoreactivity and mRNA expression within the preoptic area, spinal motor neurons (36) , and pituitary gland (27) makes this issue even more intriguing.
CGRP mRNA expression and regulation in the MPN of the female
Our findings suggest that the mechanisms underlying the regulation of CGRP mRNA expression in the MPN of the adult rat are sex specific. The gonadectomy of female rats was not found to have any impact on the numbers of hybridized cells observed in the MPN, but testosterone clearly suppressed CGRP cell number. Thus, even though ovarian steroids do not normally exert any tonic influence, the exposure of ovariectomized females to male levels of testosterone was capable of down-regulating CGRP cell number in a manner similar to that found in the male. Although at first sight this suggested that male and female CGRP neurons in the MPN used common mechanisms of gonadal steroid regulation, results with DHT and estradiol clearly demonstrated that this was not the case. We found that ER/AR coactivation was required to suppress CGRP cell numbers in the female, while either ER or AR activation alone was sufficient in the male.
Unexpectedly, we found that gonadectomy and steroid administration in the female rat resulted is divergent changes in the two measured parameters: cellular mRNA levels and the numbers of hybridized cells. A perfect correlation between changes in grain density and cell number always existed in the male. In the female, gonadectomy increased cellular silver grain density, but had no effect on CGRP cell number, whereas, to the contrary, testosterone treatment reduced cell number, but had no effect on cellular mRNA levels. Furthermore, it was apparent that either ER or AR activation was able to suppress cellular mRNA levels, whereas ER/AR coactivation was required to reduce the numbers of CGRP mRNA-expressing cells in the MPN of the female. These observations suggest that independent steroid-regulated cellular mechanisms may underlie the regulation of the numbers of potential CGRP-expressing cells and their cellular levels of CGRP mRNA in the female. Thus, the mechanisms for regulating cellular levels of CGRP mRNA in the MPN appear similar between males and females, whereas those determining the numbers of CGRP cells are sexually dimorphic.
Together, our findings suggest that the gonadal steroid regulation of CGRP mRNA expression in the female MPN probably results from multiple different mechanisms, some of which appear to be in common with the male and others that are sex specific. The requirement for ER/AR coactivation to reduce CGRP cell number in the female may provide a mechanism that protects CGRP neuronal number from suppression in the adult. For example, during proestrus, the elevated circulating estrogen concentrations will not alter CGRP cell number, as androgen levels will not be sufficiently elevated. Thus, in terms of maintaining the marked numerical sex difference in CGRP neurons, the absence of male-like levels of testosterone as well as the sex differences in ER/AR coactivation requirements are both critical.
CGRP mRNA expression and regulation in the AVPV of the female
The major unexpected finding of this study was the marked region-and sex-specific effect of testosterone to increase CGRP mRNA expression within the AVPV. To date, this is the only known situation whereby testosterone stimulates CGRP expression in the rat brain (17, 36) and is very clearly different from the situation encountered in the male AVPV and female MPN. The female-specific dependence on ER/AR coactivation for the increase in CGRP mRNA-expressing cell numbers is, nevertheless, retained in the AVPV. Although comparing across two separate CGRP in situ hybridization experiments, the 2-fold induction in CGRP cell numbers with about 1 ng/ml testosterone and the 3-fold induction with approximately 3 ng/ml testosterone suggest a dose dependency in the response. As gonadectomy has no effect on CGRP mRNA expression in the AVPV of the female, and levels of testosterone are maximal at about 0.07 ng/ml in our intact female rats (Spratt, D. P., and A. E. Herbison, unpublished data), it is unlikely that this increase is of physiological importance in the normal individual.
The very marked sex-and region-specific differences in the gonadal steroid regulation of CGRP expression revealed here in the AVPV serve to underlie the remarkable sexual dimorphism of this structure. As one of the few examples of a sexually dimorphic brain nucleus that is larger in females than in males (11, 37, 38) , the AVPV expresses abundant gonadal steroid receptors and is known to contain several sexually dimorphic neuronal phenotypes that are themselves more numerous in the female (12, 14 -16) . Although the AVPV is believed to have a critical role in the sexually differentiated transmission of gonadal steroid information to the GnRH neurons (39, 40) , a full understanding of the ontogeny and functional significance of the sexually dimorphic nature of the AVPV is lacking. In terms of differences between the AVPV and the MPN, subtle differences in the effects of gonadal steroids have sometimes been reported (41, 42) , but the complete reversal encountered here appears unique. The sexually dimorphic nature of the AVPV is thought to result from testosterone's ability to enhance cell death in the AVPV, resulting in a smaller nucleus with fewer cells in the postpubertal male (37) . Thus, it is intriguing to speculate that the cells lost in this androgen-dependent perinatal organizational process are those capable of synthesizing CGRP in response to male-like levels of testosterone in the adult female.
Conclusions
It is important that the mechanisms underlying the generation and maintenance of defined sexually dimorphic neuronal populations are elucidated to aid our understanding of the functional significance of sexually differentiated brain function (43) . The CGRP neurons of the preoptic area represent one such sexually dimorphic neuronal population in which perinatal testosterone exposure initially defines the female-dominant sex differences in neuronal number. We now report here that novel sexually differentiated region-and steroid receptor-specific ac-tivational mechanisms function in association with the sex differences in circulating testosterone levels to maintain the sexually dimorphic nature of the CGRP neuronal population in the adult rat. Unlike other characterized sexually differentiated neuronal populations, it appears that either ER or AR activation is sufficient to suppress CGRP mRNA expression in the preoptic area of the male, whereas ER/AR coactivation is required for regulation in the female. The molecular mechanisms underlying these novel events are not known. We show that ER and AR expression by CGRP neurons is also highly sexually differentiated, but this does not easily explain the sex differences observed in steroid receptor activation patterns. A further apparently unique characteristic is the ability of adult levels of testosterone to markedly increase the numbers of CGRP mRNA-expressing cells in the AVPV of the female. Although this response may be of dubious physiological relevance, the phenomenon highlights further the marked sexually differentiated, gonadal steroid-dependent plasticity of this unique nucleus.
